An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and Epilepsy
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The brain is generally considered immunoprivileged, although increasing examples of immunological responses to brain antigens, neuronal expression of major histocompatibility class I genes, and neurological autoimmunity have been recognized. An adeno-associated virus (AAV) vaccine generated autoantibodies that targeted a specific brain protein, the NR1 subunit of the N -methyl- d -aspartate (NMDA) receptor. After peroral administration of the AAV vaccine, transgene expression persisted for at least 5 months and was associated with a robust humoral response in the absence of a significant cell-mediated response. This single-dose vaccine was associated with strong anti-epileptic and neuroprotective activity in rats for both a kainate-induced seizure model and also a middle cerebral artery occlusion stroke model at 1 to 5 months following vaccination. Thus, a vaccination strategy targeting brain proteins is feasible and may have therapeutic potential for neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Gundersen, H. J. G., Bagger, P., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., MØLler, A., Nielsen, K., Nyengaard, J. R., Pakkenberg, B., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb00954.x · Cited by 2,478
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Modulation of Neuronal Migration by NMDA Receptors
Komuro, H., & Rakic, P. (1993) · Science · doi:10.1126/science.8096653 · Cited by 1,041
N-methyl-D-aspartic acid receptor structure and function
McBain, C. J., & Mayer, M. L. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.3.723 · Cited by 976
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
Young, D., Lawlor, P. A., Leone, P., Dragunow, M., & During, M. J. (1999) · Nature Medicine · doi:10.1038/7449 · Cited by 732
Self-citationAutoantibodies to Glutamate Receptor GluR3 in Rasmussen's Encephalitis
Rogers, S. W., Andrews, P. I., Gahring, L. C., Whisenand, T., Cauley, K., Crain, B., Hughes, T. E., Heinemann, S. F., & McNamara, J. O. (1994) · Science · doi:10.1126/science.8036512 · Cited by 687
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A
Das, S., Sasaki, Y. F., Rothe, T., Premkumar, L. S., Takasu, M., Crandall, J. E., Dikkes, P., Conner, D. A., Rayudu, P. V., Cheung, W., et al. (1998) · Nature · doi:10.1038/30748 · Cited by 609
Cited by
Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Shechter, R., London, A., Varol, C., Raposo, C., Cusimano, M., Yovel, G., Rolls, A., Mack, M., Pluchino, S., Martino, G., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000113 · Cited by 770
“Importantly, although our current study identifies monocytes as key players in the recovery process, our findings do not contradict the established contribution of other immune components [11,13,14,68].”
ResultThe Acid-Activated Ion Channel ASIC Contributes to Synaptic Plasticity, Learning, and Memory
Wemmie, J. A., Chen, J., Askwith, C. C., Hruska-Hageman, A. M., Price, M. P., Nolan, B. C., Yoder, P. G., Lamani, E., Hoshi, T., Freeman, J. H., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00661-x · Cited by 657
Stroke and the immune system: from pathophysiology to new therapeutic strategies
Macrez, R., Ali, C., Toutirais, O., Le Mauff, B., Defer, G., Dirnagl, U., & Vivien, D. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70066-7 · Cited by 560
Sloane, P. D., Zimmerman, S., Suchindran, C., Reed, P., Wang, L., Boustani, M., & Sudha, S. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140525 · Cited by 461
Seroprevalence of autoantibodies against brain antigens in health and disease
Dahm, L., Ott, C., Steiner, J., Stepniak, B., Teegen, B., Saschenbrecker, S., Hammer, C., Borowski, K., Begemann, M., Lemke, S., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24189 · Cited by 350
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A. W., & Silverstein, S. M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 282
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
Jooss, K., & Chirmule, N. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302037 · Cited by 277
Immune responses to adeno-associated virus and its recombinant vectors.
Sun, J. Y., Anand-Jawa, V, Chatterjee, S., & Wong, K. K. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302039 · Cited by 215
Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors
Zaiss, A. K., Cotter, M. J., White, L. R., Clark, S. A., Wong, N. C. W., Holers, V. M., Bartlett, J. S., & Muruve, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.01990-07 · Cited by 177
“However, AAV vectors can induce cellular and humoral responses to the transgene product (15, 21, 22, 41, 43, 49, 71) and AAV-mediated gene therapy leads to the development of antibodies against the vector capsid, confirming that a significant interaction with the immune system exists (9, 28, 55).”
BackgroundGardoni, F., Schrama, L. H., Kamal, A., Gispen, W. H., Cattabeni, F., & Di Luca, M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01501.2001 · Cited by 174
“NMDA receptors are of major interest because they are involved in synaptogenesis, neuronal circuitry formation, synaptic plasticity, and learning and memory, as well as in the molecular pathogenesis of neurological disorders (Hollmann and Heinemann, 1994; During et al., 2000).”
BackgroundTreatment of human disease by adeno-associated viral gene transfer
Warrington, K. H., & Herzog, R. W. (2006) · Human Genetics · doi:10.1007/s00439-006-0165-6 · Cited by 155
“Oral immunization of rats with AAV expressing the NR1 subunit of the excitatory NMDA receptor resulted in the generation of autoantibodies and ultimately reduced the neuronal firing of cells that utilize NMDA receptors (During et al. 2000).”
BackgroundAAV transcytosis through barrier epithelia and endothelium
Di Pasquale, G., & Chiorini, J. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.007 · Cited by 121
“Introduction of AAV-2 vector into the gut is reported to transduce the epithelial layer poorly but can transduce the underlying lamina propria [14,15].”
BackgroundVaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+T-Cell Responses in Mice
Lin, J., Zhi, Y., Mays, L., & Wilson, J. M. (2007) · Journal of Virology · doi:10.1128/jvi.01253-07 · Cited by 66
“AAV2 expressing a receptor to a neurotransmitter found in the brain was shown to induce autoantibodies that prevented clinical sequelae in experimentally induced stroke and epilepsy (10).”
BackgroundSelf-citation
Metadata
- Authors
- During, M. J., Symes, C. W., Lawlor, P. A., Lin, J., Dunning, J., Fitzsimons, H. L., Poulsen, D., Leone, P., Xu, R., Dicker, B. L., Lipski, J., & Young, D.
- Venue
- Science
- Published
- 2000-02-25
- Volume
- 287
- Issue
- 5457
- Pages
- 1453-1460
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1675918302
- Cited by
- 220
- References
- 31
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.